Comparative analysis of hepatopulmonary shunt obtained from pretherapy 99mTc MAA scintigraphy and post-therapy 90Y Bremsstrahlung imaging in 90Y microsphere therapy

Nuclear Medicine Communications

Volumn 33, Issue 5, 2012, Pages 486-490

  Jha, Ashish Kumar A ^a   Zade, Anand A ^a   Rangarajan, Venkatesh ^a   Purandare, Nilendu ^a   Shah, Sneha A ^a   Agrawal, Archi ^a   Kulkarni, Suyash S ^a   Shetty, Nitin ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

90Y Bremsstrahlung imaging; 90Y microsphere therapy; hepatopulmonary shunt; macroaggregate albumin scintigraphy

Indexed keywords

MACROSALB TC 99M; MICROSPHERE; YTTRIUM 90;

ACCURACY; ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; BREMS RADIATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; HEPATOPULMONARY SHUNT; HUMAN; LIVER CANCER; SCINTIGRAPHY; SHUNTING;

ADULT; AGED; EMBOLIZATION, THERAPEUTIC; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LIVER NEOPLASMS; LUNG; MICROSPHERES; MIDDLE AGED; PARTICLE SIZE; PROGNOSIS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; TECHNETIUM TC 99M AGGREGATED ALBUMIN; YTTRIUM RADIOISOTOPES;

EID: 84859432761     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e328351672d     Document Type: Article

References (19)

1. Koch W, Tattch K. Different properties of macroaggregated albumin and SIRspheres; liver radioembolisation with 90Y microspheres: medical radiology diagnostic imaging. Verlag Berlin Heidelberg: Springer; 2008; p. 86.
2. Owunwanne A, Patel M, Sadek S. Preparation, technetium-99m macroaggregate albumin, handbook of radiopharmaceuticals. London: Chapman and Hall; 1995; p. 67.
3. Lawrence TS, Robertson JM, Anscher MS, Jirtle RL, Ensminger WD, Fajardo LF. Hepatic toxicity resulting from cancer treatment. Int Radiat Oncol Biol Phys 1995; 31:1237-1248.
4. Salem R, Lewandowski RJ, Atassi B, Gordon SC, Gates VL, Barakan O, et al. Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival. J Vasc Interv Radiol 2005; 16:1627-1639. (Pubitemid 44431160)
5. Shen S, DeNardo GL, Yuan A, DeNardo DA, DeNardo SJ. Planar gamma camera imaging and quantitation of yttrium-90 bremsstrahlung. J Nucl Med 1994; 35:1381-1389. (Pubitemid 24243156)
6. Zade A, Jha A, Monterior P, Nair S, Shetye B, Shah S, et al. Optimisation of acquisition parameters for Bremsstrahlung imaging of 89Sr and 90Y. Indian J Nucl Med 2010; 25:121-126.
7. Carr BI. Hepatic artery chemoembolization for advanced stage HCC: experience of 650 patients. Hepatogastroenterology 2002; 49:79-86. (Pubitemid 34289490)
8. Murthy R, Nunez R, Szklaruk J, Erwin W, Madoff DC, Gupta S, et al. Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications. Radiographics 2005; 25 (suppl 1):S41-S55. (Pubitemid 41686061)
9. Salem R, Thurston KG. Radioembolization with yttrium-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 3- comprehensive literature review and future direction. J Vasc Interv Radiol 2006; 17:1571-1593. (Pubitemid 44596135)
10. Szyszko T, Al-Nahhas A, Tait P, Rubello D, Canelo R, Habib N, et al. Management and prevention of adverse effects related to treatment of liver tumours with 90Y microspheres. Nucl Med Commun 2007; 28:21-24. (Pubitemid 44949684)
11. Jiao LR, Szyszko T, Al-Nahhas A, Tait P, Canelo R, Stamp G, et al. Clinical and imaging experience with yttrium-90 microspheres in the management of unresectable liver tumours. Eur J Surg Oncol 2007; 33:597-602. (Pubitemid 46746540)
12. Leung TW, Lau WY, Ho SK,Ward SC, Chow JH, Chan MS, et al. Radiation pneumonitis after selective internal radiation treatment with intraarterial 90yttrium-microspheres for inoperable hepatic tumors. Int J Radiat Oncol Biol Phys 1995; 33:919-924.
13. Yip D, Allen R, Ashton C, Jain S. Radiation-induced ulceration of the stomach secondary to hepatic embolization with radioactive yttrium microspheres in the treatment of metastatic colon cancer. J Gastroenterol Hepatol 2004; 19:347-349. (Pubitemid 38338751)
14. Goin JE, Salem R, Carr BI, Dancey JE, Soulen MC, Geschwind JFH, et al. Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities. J Vasc Interv Radiol 2005; 16:205-213. (Pubitemid 40322293)
15. Kennedy A, Nag S, Salem R, Murthy R, McEwan AJ, Nutting C, et al. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys 2007; 68:13-23. (Pubitemid 46589861)
16. Denecke T, Ruhl R, Hildebrandt B, Stelter L, Grieser C, Stiepani H, et al. Planning transarterial radioembolisation of colorectal liver metastases with yttrium 90 microspheres: evaluation of a sequential diagnostic approach using radiologic and nuclear medicine imaging techniques. Eur Radiol 2008; 18:892-902.
17. Zeissman HA, Thrall JH, Yang PJ, Walker SC, Cozzi EA, Niederhuber JE, et al. Hepatic arterial perfusion scintigraphy with Tc-99m MAA. Radiology 1984; 152:167-172.
18. Clarke LP, Si Cullom, Shaw R, Reece C, Penney BC, King MA, et al. Bremsstrahlung imaging using the gamma camera: factors affecting attenuation. J Nucl Med 1992; 33:161-166.
19. Smith T, Crawley JCW, Shawe DJ, Gumpel JM. SPECT using bremsstrahlung to quantify yttrium-90 uptake in Baker's cysts: its application in radiation synovectomy of the knee. Eur J Nucl Med 1988; 14: 498-503.